SCHEMBL23966828

SCHEMBL23966828

Cc1cccc2c1C(=O)O/C2=C/COC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 6/20 0.39
HPGD P15428 6/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2C19 P33261 3/20 0.39
NPC1 O15118 3/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CYP3A4 P08684 2/20 0.39
TRPA1 O75762 1/20 0.38
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
POLB P06746 2/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23966829 0.79 ALDH1A1 (0.36) ALDH1A1TSHRMAPK1KDM4EHPGD
SCHEMBL23914735 0.76 KDM4E (0.40) ALDH1A1TSHRMAPK1KDM4EHPGD
SCHEMBL29539686 0.66 ALOX15 (0.52) ALDH1A1TSHRMAPK1KDM4EHPGD
SCHEMBL166198 0.66 ALOX15 (0.52) ALDH1A1TSHRMAPK1KDM4EHPGD
SCHEMBL28456026 0.66 CA1 (0.44) ALDH1A1TSHRMAPK1KDM4ECYP1A2
SCHEMBL22259113 0.65 MAPT (0.59) ALDH1A1KDM4EHPGDCYP1A2CYP2C19
SCHEMBL23914740 0.62 CA1 (0.44) ALDH1A1KDM4EHPGDCYP1A2CYP2C19
SCHEMBL1688847 0.62 ALDH1A1 (0.55) ALDH1A1TSHRMAPK1CYP1A2NPC1
SCHEMBL3751329 0.62 TRPA1 (0.62) ALDH1A1TSHRMAPK1KDM4EHPGD
SCHEMBL3751327 0.62 TRPA1 (0.62) ALDH1A1TSHRMAPK1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed